News from the academia
University centre, students tackling cancer in high-risk state
The Centre for Health and Human Services (CHHS) at Middle Tennessee State University is planning to set up a Tennessee Colorectal Cancer Screening Pilot Program that will give colorectal cancer screening access to low-income residents of Tennessee. The state ranks 3rd in the US in cancer mortality rates. Colorectal cancer is the 2nd leading cause of cancer deaths in the state. The CHHS will be working together with the Tennessee Comprehensive Cancer Control Coalition to find the reason why Tennessee ranks so high in cancer.
News from the stem cell researchers
Breakthrough makes lab-produced stem cells safer for humans
British and Canadian researchers may have found a way to overcome the barriers that prevent stem cells made from skin cells from being transplanted to humans safely. The development of stem cells from skin cells made headlines in 2006 as a major breakthough in stem cell research. However, its clinical application was hindered by health risks associated with the transplantation.
News from the regulators
FDA Greenlights New Drug for Advanced Kidney Cancer
The US FDA has approved everolimus (Afinitor) for the treatment of renal cell carcinoma. (advanced kidney cancer). Afinitor does not cure the cancer but delays the spread and reduces the growth of the tumors by about 5 months. Afinitor is manufactured by Novartis.
News from the statisticians
Lead Story: Hospital Admissions on the Rise for People Without Health Insurance
The U.S. Agency for Healthcare Research and Quality (AHRQ) reports that hospital admissions of people without health insurance coverage are up by a third between 1997 and 2006. AHRQ presented the numbers and the story in a podcast last Wednesday, April 9.
News from the genetic experts
New ACOG Guidelines Recommend Routine Genetic Risk Assessment
The American College of Obstetricians and Gynecologists (ACOG) and the Society of Gynecologic Oncologists (SGO) have just released new guidelines which recommend that women should be routine assessed for genetic predisposition foe break can ovarian cancer. Women who eventually undergo genetic testing and are found to carry a BRCA1 or BRCA2 gene mutation have options available to manage their increased risk of cancer. These guidelines were published in Obstetrics and Gynecology.
News from the advocacy groups
Cancer activities for April
The season has started for walking or running events at your local Susan Komen chapters. Whether you are a leisurely walker or a marathon runner, there is an event for you to participate in. Register now!